Vivos (RDGL) Gross Margin Growth (1y) (2011 - 2025)
Vivos (RDGL) Gross Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 128.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 448.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 60.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 305.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -6.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 391.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 153.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -4,158.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 69.00 |
| 10 | Vivos | 22.64 Mn | 21.08 Mn | -3,105.00 | 9,326.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9,326.00 |
| Sep 30, 2025 | -70,363.00 |
| Jun 30, 2025 | -25,183.00 |
| Mar 31, 2025 | -62.00 |
| Sep 30, 2024 | -7,838.00 |
| Jun 30, 2024 | 5,861.00 |
| Mar 31, 2024 | -773.00 |
| Sep 30, 2023 | 20,054.00 |
| Jun 30, 2023 | -11,924.00 |
| Mar 31, 2023 | -10,252.00 |
| Sep 30, 2022 | -16,023.00 |
| Mar 31, 2015 | -145.00 |
| Mar 31, 2014 | 1,659.00 |
| Sep 30, 2013 | -5,243.00 |
| Mar 31, 2013 | 875.00 |
| Dec 31, 2012 | -122.00 |
| Sep 30, 2012 | -335.00 |
| Jun 30, 2012 | -2,597.00 |
| Mar 31, 2012 | -1,047.00 |
| Dec 31, 2011 | -1,474.00 |